Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Jansen

Showing results (181-190 of 254) with videos related to

Pageof 26
Sort By:
Plos One|September 15, 2017
Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoiresBin Jia, Lisa K McNeil, Christopher D Dupont, et al.
Clinical and Diagnostic Laboratory Immunology|August 9, 2005
Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18Dennis Dias, Jeff Van Doren, Sonela Schlottmann, et al.
Open Forum Infectious Diseases|July 21, 2025
Dynamics of Respiratory Syncytial Virus Illness and Serology During Pregnancy and Infancy in the United States and South AfricaShabir A Madhi, Eric A F Simões, Nicola P Klein, et al.
The Lancet. Infectious Diseases|October 18, 2016
Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trialHelen S Marshall, Peter C Richmond, Johannes Beeslaar, et al.
Plos One|February 27, 2015
Evaluation of approaches to monitor Staphylococcus aureus virulence factor expression during human diseaseWouter Rozemeijer, Pamela Fink, Eduardo Rojas, et al.
The Lancet. Infectious Diseases|May 10, 2012
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trialPeter C Richmond, Helen S Marshall, Michael D Nissen, et al.
Journal of the Pediatric Infectious Diseases Society|September 26, 2015
Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy AdolescentsTimo Vesikari, Lars Østergaard, Javier Diez-Domingo, et al.
Clinical and Vaccine Immunology : CVI|June 8, 2012
Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urineMichael W Pride, Susanne M Huijts, Kangjian Wu, et al.
Vaccine|February 10, 2009
Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: implications for vaccine designJasdeep S Nanra, Yekaterina Timofeyeva, Sandra M Buitrago, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 14, 2017
Meningococcal carriage in Dutch adolescents and young adults; a cross-sectional and longitudinal cohort studyM B van Ravenhorst, M W Bijlsma, M A van Houten, et al.
Pageof 26

Showing results (181-190 of 254) with videos related to

Sort By:
Pageof 26
Plos One|September 15, 2017
Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoiresBin Jia, Lisa K McNeil, Christopher D Dupont, et al.
Clinical and Diagnostic Laboratory Immunology|August 9, 2005
Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18Dennis Dias, Jeff Van Doren, Sonela Schlottmann, et al.
Open Forum Infectious Diseases|July 21, 2025
Dynamics of Respiratory Syncytial Virus Illness and Serology During Pregnancy and Infancy in the United States and South AfricaShabir A Madhi, Eric A F Simões, Nicola P Klein, et al.
The Lancet. Infectious Diseases|October 18, 2016
Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trialHelen S Marshall, Peter C Richmond, Johannes Beeslaar, et al.
Plos One|February 27, 2015
Evaluation of approaches to monitor Staphylococcus aureus virulence factor expression during human diseaseWouter Rozemeijer, Pamela Fink, Eduardo Rojas, et al.
The Lancet. Infectious Diseases|May 10, 2012
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trialPeter C Richmond, Helen S Marshall, Michael D Nissen, et al.
Journal of the Pediatric Infectious Diseases Society|September 26, 2015
Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy AdolescentsTimo Vesikari, Lars Østergaard, Javier Diez-Domingo, et al.
Clinical and Vaccine Immunology : CVI|June 8, 2012
Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urineMichael W Pride, Susanne M Huijts, Kangjian Wu, et al.
Vaccine|February 10, 2009
Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: implications for vaccine designJasdeep S Nanra, Yekaterina Timofeyeva, Sandra M Buitrago, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 14, 2017
Meningococcal carriage in Dutch adolescents and young adults; a cross-sectional and longitudinal cohort studyM B van Ravenhorst, M W Bijlsma, M A van Houten, et al.
Pageof 26